
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MPST CRISPR/Cas9 KO Plasmid (h) | sc-401643 | 20 µg | $397.00 |
Human MPST (3-mercaptopyruvate sulfurtransferase) is a mitochondrial and cytosolic sulfurtransferase that catalyzes conversion of 3-mercaptopyruvate to pyruvate while generating reactive sulfur species and contributing to endogenous hydrogen sulfide (H2S) and persulfide metabolism. MPST functions in cellular redox homeostasis, sulfur amino acid utilization, and regulation of protein persulfidation, with downstream effects on mitochondrial bioenergetics and stress-response signaling. Altered MPST activity has been linked to oxidative stress sensitivity and metabolic dysregulation, and changes in MPST expression or sulfur signaling are studied in contexts such as neurobiology, cardiovascular signaling, and cancer cell adaptation. As part of the broader transsulfuration and reactive sulfur network, MPST provides a mechanistic entry point to dissect thiol-dependent signaling and mitochondrial function.
MPST CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the MPST gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the MPST together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the MPST open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MPST protein expression.
This CRISPR knockout system enables efficient generation of MPST-deficient cell models for investigation of MPST signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.